Effect of cyclosporin A, azathioprine, and prednisolone on carbohydrate metabolism of rat hepatocytes.
The effect of different immunosuppressive drugs (prednisolone, azathioprine, cyclosporin A) on liver carbohydrate metabolism in the rat was investigated. Daily administration of prednisolone (3 mg/kg body weight) and azathioprine (2 mg/kg body weight) intraperitoneally for 2 weeks caused significantly lower liver glycogen content than that in NaCl-treated controls. Liver glucose and lactate content, as well as plasma glucose, glucagon, and serum insulin concentration of these animals, remained unchanged. There were no differences in any of these parameters between cyclosporin A (15 mg/kg body weight)-treated and vehicle (olive oil/ethanol)-treated animals. Prednisolone caused significantly lower glucose production in isolated rat hepatocytes using Na-pyruvate as the substrate, whereas glucose production was unchanged in hepatocytes of azathioprine-treated rats using pyruvate or L-serine as substrates. Glucose production from pyruvate or serine was significantly inhibited by cyclosporin A compared to the vehicle, but did not differ from the effects of azathioprine and prednisolone. Lactate production was significantly lower in cyclosporin-treated animals than in those given either the vehicle or azathioprine. Cyclosporin A completely reversed the inhibition of hepatocyte glycogen consumption caused by the vehicle. However, glycogen production in the presence of cyclosporin A was comparable to the effects of prednisolone and azathioprine. Finally, hepatocyte ketone body production using pyruvate as the substrate was higher in the presence of all immunosuppressive drugs. In the presence of serine, acetoacetate production increased in rats treated with 50 mg/kg body weight cyclosporin A, and beta-hydroxybutyrate production in animals receiving 15 and 50 mg/kg body weight cyclosporin A.
Riegel
W
W
Department of Medicine, University of Freiburg, Federal Republic of Germany.
Stephan
E
E
Ballé
C
C
Heidland
A
A
Hörl
W H
WH
D000704:Analysis of Variance; D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D050260:Carbohydrate Metabolism; D002478:Cells, Cultured; D003524:Cyclosporins / Q000008:administration & dosage / Q000494:pharmacology*; D005947:Glucose / Q000096:biosynthesis; D007165:Immunosuppression Therapy; D007773:Lactates / Q000096:biosynthesis; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008112:Liver Glycogen / Q000096:biosynthesis; D011239:Prednisolone / Q000008:administration & dosage / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D001786:Blood Glucose; D003524:Cyclosporins; D007773:Lactates; D008112:Liver Glycogen; D011773:Pyruvates; D011239:Prednisolone; D005947:Glucose; D001379:Azathioprine